Table 3.
Adherence features according to the GMAS in each disease group.
| Medication Adherence | Medication Adherence | OR (95% CI) |
p * | ||
|---|---|---|---|---|---|
| Adherence n (%) |
Non-Adherence n (%) |
||||
| Non-adherence due to patient behavior | Cardiovascular | 471 (67.9) | 223 (32.1) | 1 | - |
| Endocrine–metabolic | 299 (73.8) | 106 (26.2) | 1.336 (1.017–1.755) |
0.037 | |
| Both of them | 211 (61.2) | 134 (38.8) | 0.746 (0.570–0.975) |
0.032 | |
| Total | 981 (67.9) | 463 (32.1) | |||
| Non-adherence due to additional disease and pill burden | Cardiovascular | 571 (82.3) | 123 (17.7) | 1 | - |
| Endocrine–metabolic | 327 (80.7) | 78 (19.3) | 0.903 (0.659–1.237) |
0.525 | |
| Both of them | 266 (77.1) | 79 (22.9) | 0.725 (0.528–0.997) |
0.047 | |
| Total | 1164 (80.6) | 280 (19.4) | |||
| Non-adherence due to financial constraints | Cardiovascular | 129 (18.6) | 565 (81.4) | 1 | - |
| Endocrine–metabolic | 92 (22.7) | 313 (77.3) | 1.287 (0.952–1.739) |
0.1 | |
| Both of them | 99 (28.7) | 246 (71.3) | 1.763 (1.304–2.383) |
<0.001 | |
| Total | 320 (22.2) | 1124 (77.8) | |||
* p: comparing the difference between endocrine–metabolic patients and patients of both diseases (cardiovascular and metabolism).